Chandramouli Nagarajan

机构：Singapore General Hospital · ORCID：0000-0001-5755-2226

发表论文 128 篇 · 总被引 863 次 · h-index 12

代表论文

• International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma (2025 · Leukemia · 被引 60)
• Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study (2025 · Journal of Clinical Oncology · 被引 4)
• Imaging in plasma cell disorders—consensus recommendations of the Asian myeloma network bone imaging workgroup (2025 · The Lancet Regional Health - Western Pacific · 被引 2)
• Extracellular viral microRNAs as biomarkers of virus infection in human cells (2024 · Molecular Therapy — Nucleic Acids · 被引 2)
• Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's Lymphoma (2025 · JCO Precision Oncology · 被引 1)
• A phase 2 study of Daratumumab with Thalidomide and dexamethasone in relapsed and/or Refractory Myeloma (RRMM) (2025 · Blood Cancer Journal · 被引 1)